Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
A randomised trial of interval debulking surgery in epithelial ovarian cancer suboptimally debulked at primary surgery
ISRCTN ISRCTN84121653
DOI 10.1186/ISRCTN84121653
ClinicalTrials.gov identifier NCT00003695
EudraCT number
Public title A randomised trial of interval debulking surgery in epithelial ovarian cancer suboptimally debulked at primary surgery
Scientific title
Acronym N/A
Serial number at source OV06
Study hypothesis To determine the impact of interval debulking surgery in newly diagnosed ovarian cancer in patients with residual macroscopic disease after surgery.
Lay summary Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cancer
Participants - inclusion criteria 1. Newly diagnosed, histologically confirmed epithelial ovarian cancer
2. International Federation of Gynecology and Obstetrics (FIGO) stage II, III or IV
3. Residual macroscopic disease more than 1 cm in diameter documented at primary surgery or post-operatively by imaging
4. Patient planned to receive platinum-based chemotherapy
5. Patient fit for interval debulking surgery
6. No concomitant or previous malignancy likely to interfere with protocol treatments or comparisons
7. Written informed consent
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/04/1998
Anticipated end date 26/07/2001
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 1000
Interventions One group interval debulking surgery/control
Primary outcome measure(s) Survival, progression-free survival and quality of life
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Medical Research Council (MRC) (UK)
Trial website
Publications
Contact name Ms  Sarah  Wheeler
  Address MRC Clinical Trials Unit
222 Euston Road
  City/town London
  Zip/Postcode NW1 2DA
  Country United Kingdom
  Email
Sponsor Medical Research Council (MRC) (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Tel +44 (0)20 7636 5422
  Fax +44 (0)20 7436 6179
  Email clinical.trial@headoffice.mrc.ac.uk
  Sponsor website: http://www.mrc.ac.uk
Date applied 06/04/2000
Last edited 06/06/2012
Date ISRCTN assigned 06/04/2000
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.